Goldman Sachs
EVH icon

Goldman Sachs’s Evolent Health EVH Stock Holding History

Goldman Sachs’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-72,200
Closed -$653K – 5296
2019
Q4 		$653K Hold
72,200
– – ﹤0.01% 4354
2019
Q3 		$519K Buy
+72,200
New +$518K ﹤0.01% 4432

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs's EVH Position: Q1 2026 in Review

Goldman Sachs increased its Evolent Health (EVH) stake by 22% in Q1 2026, buying an estimated $1.28M and bringing the position to 2,236,606 shares worth $5.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

Goldman Sachs first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $34.9M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Goldman Sachs held 2,236,606 shares of Evolent Health worth $5.1M as of Q1 2026.
  • Goldman Sachs bought 403,111 Evolent Health shares in Q1 2026, an estimated $1.28M.
  • Evolent Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3672 holding.
  • Goldman Sachs first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Goldman Sachs's Evolent Health position peaked at $34.9M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.